PBMs make more money when a drug's list price increases, while patients bear the financial burden.
Bob Menendez: “PBMs make more money when a drug's list price increases, while patients bear the financial burden.”
On the recordMarch 30, 2023
Source
congress.govEditor's note · Context
Menendez highlights the conflict of interest in PBM pricing structures.
Share
More from Bob Menendez
Apr 1, 2025
In recent weeks, the Trump administration and House Republicans have set their sights on the Federal judiciary, calling for unprecedented changes to our courts, attacking the character of dedicated Federal judges, and attempting to…
Jul 23, 2024
Increase awareness. More information for communities to put pressure on those local actors to try to make those changes in a quicker fashion.
Sep 10, 2025
I rise today in memory of Sarah Katz, an empathetic, driven, and compassionate young woman, whose life was tragically cut short 3 years ago today. A native of Jersey City and graduate of Elisabeth Irwin High School in New York, Sarah…





